What is the average price target for CONOCOPHILLIPS (COP) stock?
33 analysts have analysed COP and the average price target is 119.02 USD. This implies a price decrease of -1.9% is expected in the next year compared to the current price of 121.32.
NYSE:COP • US20825C1045
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CONOCOPHILLIPS (COP).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-16 | Barclays | Maintains | Overweight -> Overweight |
| 2026-03-12 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-03-05 | UBS | Maintains | Buy -> Buy |
| 2026-03-02 | Citigroup | Maintains | Buy -> Buy |
| 2026-02-17 | Roth Capital | Downgrade | Buy -> Neutral |
| 2026-02-09 | Citigroup | Maintains | Buy -> Buy |
| 2026-02-06 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-02-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-06 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-26 | Susquehanna | Maintains | Positive -> Positive |
| 2026-01-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-01-20 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2026-01-16 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2026-01-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-12 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2026-01-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-05 | Bernstein | Maintains | Outperform -> Outperform |
| 2025-12-12 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-12-12 | UBS | Maintains | Buy -> Buy |
| 2025-12-05 | Johnson Rice | Downgrade | Accumulate -> Hold |
| 2025-11-12 | UBS | Maintains | Buy -> Buy |
| 2025-10-20 | Susquehanna | Maintains | Positive -> Positive |
| 2025-10-17 | Wells Fargo | Initiate | Equal-Weight |
| 2025-10-14 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-13 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 56.141B -28.48% | 54.745B -2.49% | 58.944B 7.67% | 56.579B -4.01% | 60.235B 6.46% | 67.042B 11.30% | 69.239B 3.28% | 77.878B 12.48% | N/A | |
| EBITDA YoY % growth | 23.137B -29.70% | 22.105B -4.46% | 22.762B 2.97% | 23.104B 1.50% | 25.628B 10.92% | 27.635B 7.83% | 29.617B 7.17% | 31.762B 7.24% | 31.587B -0.55% | |
| EBIT YoY % growth | 14.867B -41.48% | 12.506B -15.88% | 11.262B -9.95% | 10.177B -9.63% | 12.65B 24.30% | 17.292B 36.70% | 19.075B 10.31% | 19.776B 3.67% | 21.754B 10.00% | |
| Operating Margin | 26.48% | 22.84% | 19.11% | 17.99% | 21.00% | 25.79% | 27.55% | 25.39% | N/A | |
| EPS YoY % growth | 8.78 -34.91% | 7.77 -11.50% | 6.14 -20.98% | 4.93 -19.70% | 6.60 33.87% | 8.31 25.96% | 10.02 20.57% | 11.90 18.72% | 13.86 16.44% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.16 -44.30% | 1.07 -24.30% | 1.50 -6.71% | 1.66 62.41% | 1.99 70.82% | 1.92 78.19% | 2.05 36.49% | 2.15 29.84% | 1.57 -20.87% | 1.55 -18.91% | 1.58 -22.94% |
| Revenue Q2Q % growth | 14.219B -16.85% | 13.737B -6.80% | 14.932B -3.80% | 15.67B 10.47% | 16.204B 13.96% | 16.211B 18.01% | 16.766B 12.28% | 17.002B 8.50% | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 5.805B -16.80% | 5.627B -31.37% | 6.138B -45.72% | 6.383B -52.44% | 6.763B 16.50% | 6.638B 17.97% | 6.904B 12.48% | 7.03B 10.14% | 6.043B -10.65% | 5.943B -10.47% | 5.958B -13.70% |
| EBIT Q2Q % growth | 2.804B -33.73% | 2.506B -4.17% | 3.192B 13.72% | 3.612B 88.13% | 3.94B 40.51% | 3.748B 49.56% | 4.02B 25.94% | 4.127B 14.26% | N/A | N/A | N/A |
All data in USD
33 analysts have analysed COP and the average price target is 119.02 USD. This implies a price decrease of -1.9% is expected in the next year compared to the current price of 121.32.
CONOCOPHILLIPS (COP) will report earnings on 2026-05-06, before the market open.
The consensus EPS estimate for the next earnings of CONOCOPHILLIPS (COP) is 1.16 USD and the consensus revenue estimate is 14.22B USD.
The consensus rating for CONOCOPHILLIPS (COP) is 78.7879 / 100 . This indicates that analysts generally have a positive outlook on the stock.